<DOC>
	<DOCNO>NCT01200615</DOCNO>
	<brief_summary>In study invetigate influence nocebo effect ( part obtain informed consent ) prevalence side-effects . The study prospective , focus connection physician say patient side-effects frequency side effect treatment period . We also inquire whether inform patient existence nocebo effect influence extent phenomenon .</brief_summary>
	<brief_title>The Nocebo Effect : Prospective Study Informed Consent Factor Prevalence SSRI 's Side Effects</brief_title>
	<detailed_description>In study investigator wish inquire whether nature explenation give patient part inform consent effect prevalence side-effects . The study take place out-patient clinic Shalvata Mental health Center . Three arm include : 1 . 50 patient start SSRI 's updated common side effect 2 . 50 patient start SSRI 's updated common side effect receive explenation nocebo effect 3 . 50 patient start SSRI 's receive explenation nocebo effect , updated common side-effects . Nonetheless , inform severe side-effects . Following prescription SSRI subject enter follow-up phase study . They attend two follow-up meeting : 3 day initiation point one month start point . During meeting ask fill Antidepressant Side-Effect Checklist ( ASEC ) General Health Questionnaire ( GHQ ) .</detailed_description>
	<criteria>1. age 1860 2. start SSRI Psychotic spectrum disorder Suicidality Sensitivity SSRI Has take prescribe SSRI past</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>nocebo side-effects SSRI inform consent</keyword>
</DOC>